MTMerve Begum Terzi

Merve Begum Terzi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Merve Begum Terzi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Machine learning based hybrid anomaly detection technique for automatic diagnosis of cardiovascular diseases using cardiac sympathetic nerve activity and electrocardiogram

    by Merve Begum Terzi, Orhan Arikan

    Objectives: Coronary artery diseases (CADs) are the leading cause of death worldwide and early diagnosis is crucial for timely treatment. To address this, our study presents a novel automated Artificial Intelligence (AI)-based Hybrid Anomaly Detection (AIHAD) technique that combines various signal processing, feature extraction, supervised, and unsupervised machine learning methods. By jointly and simultaneously analyzing 12-lead cardiac sympathetic nerve activity (CSNA) and electrocardiogram (ECG) data, the automated AIHAD technique performs fast, early, and accurate diagnosis of CADs. Methods: In order to develop and evaluate the proposed automated AIHAD technique, we utilized the fully labeled STAFF III and PTBD databases, which contain the 12-lead wideband raw recordings non-invasively acquired from 260 subjects. Using these wideband raw recordings, we developed a signal processing technique that simultaneously detects the 12-lead CSNA and ECG signals of all subjects. Using the pre-processed 12-lead CSNA and ECG signals, we developed a time-domain feature extraction technique that extracts the statistical CSNA and ECG features critical for the reliable diagnosis of CADs. Using the extracted discriminative features, we developed a supervised classification technique based on Artificial Neural Networks (ANNs) that simultaneously detects anomalies in the 12-lead CSNA and ECG data. Furthermore, we developed an unsupervised clustering technique based on Gaussian mixture models (GMMs) and Neyman-Pearson criterion, which robustly detects outliers corresponding to CADs. Results: Using the automated AIHAD technique, we have, for the first time, demonstrated a significant association between the increase in CSNA signals and anomalies in ECG signals during CADs. The AIHAD technique achieved highly reliable detection of CADs with a sensitivity of 98.48 %, specificity of 97.73 %, accuracy of 98.11 %, positive predictive value of 97.74 %, negative predictive value of 98.47 %, and F1-score of 98.11 %. Hence, the automated AIHAD technique demonstrates superior performance compared to the gold standard diagnostic test ECG in the diagnosis of CADs. Additionally, it outperforms other techniques developed in this study that separately utilize either only CSNA data or only ECG data. Therefore, it significantly increases the detection performance of CADs by taking advantage of the diversity in different data types and leveraging their strengths. Furthermore, its performance is comparatively better than that of most previously proposed machine and deep learning methods that exclusively used ECG data to diagnose or classify CADs. Additionally, it has a very low implementation time, which is highly desirable for real-time detection of CADs. Conclusions: The proposed automated AIHAD technique may serve as an efficient decision-support system to increase physicians’ success in fast, early, and accurate diagnosis of CADs. It may be highly beneficial and valuable, particularly for asymptomatic patients, for whom the diagnostic information provided by ECG alone is not sufficient to reliably diagnose the disease. Hence, it may significantly improve patient outcomes by enabling timely treatments and considerably reducing the mortality of cardiovascular diseases (CVDs).


  • Open Access

    Artificial Intelligence-Based Hybrid System for COVID-19 Diagnosis Using RT-PCR, Thorax CT and Laboratory Data

    by Elvan Burak Verdi, Merve Begum Terzi, Deniz Doğan Mülazimoğlu, Mehmetcan Gök, Aslıhan Gürün Kaya, Serhat Erol, Özlem Işık, Onur Utku Güvendik, Çağlar Uzun, Atilla Halil Elhan, et al.

    Background: During the early stages of the COVID-19 pandemic, physicians faced difficulties in radiological differential diagnosis and low sensitivity in microbiological testing. Delay in diagnosis and isolation hinders pandemic control. Artificial intelligence (AI) could help diagnose COVID-19 rapidly and accurately. We aimed to design a single AI algorithm using RT-PCR, thorax CT (TCT), and laboratory data to diagnose COVID-19 more accurately. Methods: We retrospectively created the Ankara University Faculty of Medicine COVID-19 database. Additionally, a ground-glass opacities (GGO) database was constructed for the differential diagnosis of COVID-19 pneumonia (CP). TCTs of parenchymal lung diseases with GGO involvement (PLD), non-COVID-19 viral or bacterial pneumonia with GGO (VBP), and healthy subjects (as controls) were compared. A hybrid algorithm was developed for COVID-19 diagnosis using RT-PCR curves, TCT images, and laboratory data. Findings: The TCT model diagnosed CP with >90% sensitivity and specificity. Moreover, it could distinguish between VBP and PLD with a success rate of >80%. The RT-PCR model detected COVID-19 with 96·6% sensitivity, outperforming the gold-standard RT-PCR test. The sensitivity of the hybrid model quadruple classification was 66·3%, and Cohen’s kappa was 0·75±0·02 (p<0·001). Interpretation: Although the performance scores of the TCT and RT-PCR models were high, the diagnostic success of the hybrid algorithm was lower. This is the first hybrid AI study to diagnose COVID-19 using TCT, RT-PCR, and laboratory data. This algorithm synthesises the perspectives of clinicians, radiologists, and microbiologists and has excellent potential for sharing responsibilities at critical points in medicine. Trial Registration Details: The study design has been registered at www.clinicaltrials.gov (NCT04479319). Funding Information: This study was funded by the Health Institutes of Turkey (government agency) under the Strategic Research and Development Projects Support Program [Grant No: 2020-CV-01, Project no: 9081]. Declaration of Interests: The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this manuscript. Ethics Approval Statement: The AUFM ethics committee approved the study protocol (I8-501-20). All data were anonymised.